Clinical trial
Observational Study of NovoNorm® in Subjects With Diabetes
NCT01498913
Study timeline
Study start (actual)2001-08-30Date precision: day
Registry last updated2017-02-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetesunresolved
Diabetes Mellitus, Type 2unresolved
Interventions
repaglinideDRUG · verified · RxNorm: repaglinide
Sponsors & collaborators
Novo Nordisk A/Slead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01498913 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.